返回 Agendas
PMDA Town Hall
Session Chair(s)
Toshiyoshi Tominaga, PhD
Life Science Department, Advisor
SunFlare Co., Ltd, Japan
Representatives from PMDA will explain the progress of its third Five-Year Mid-Term plan, including the future initiative/challenges for faster review and better life cycle management of drugs. The audience will be provided an opportunity to ask questions to the panel.
Learning Objective : Recognize the latest progress of PMDA and Japanese regulation; Discuss with PMDA senior officials Japanese regulatory issues.
Speaker(s)
New Regulation in Japan and Future Direction of PMDA
Tatsuya Kondo, MD, PhD
SH Medical Excellence JAPAN, Japan
President
Science-based Initiatives of PMDA
Takao Yamori
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Executive Director
New Streams of Risk Management
Tomiko Tawaragi
RAD-AR Council, Japan
Director
PMD Act and SAKIGAKE Strategy
Nobumasa Nakashima
Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan
Professor
注册方法
Registration override should work.